Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT07213804
Protocol Title: FRAmework-01: A Two-Part Phase 3 Study of LY4170156 versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and LY4170156 plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer
Status
Open
Conditions
Ovary
Phases
3 (Cancer Control)
Age Group
Adult
Main Investiagtor
Hand, Lauren
Practice
Gyn
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT07213804
Secondary Trial ID Number
J5E-MC-JZXB / FRAmework-01
Keywords
Treatment